Stock detail
Alnylam Pharmaceuticals, Inc (ALNY) stock price, chart, and key data
View Alnylam Pharmaceuticals, Inc stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alnylam Pharmaceuticals, Inc
ALNY · XNAS
$252.90
-1.98%
-$5.10
Key metrics
52-week range
$8.25 - $3.00
Close price
$258.00
Market cap
$34.5B
P/E ratio
43.88
Beta
0.6
About the company
Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$377
19
Buy
/ 22
Recent calls
09/08/2026
Jefferies
Faisal Khurshid
Hold · Price target $260
09/02/2026
H.C. Wainwright
Patrick Trucchio
Buy · Price target $455
09/01/2026
Barclays
Eliana Merle
Buy · Price target $450
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Dan Goldman democrat · House · NY-10 self |
| $30,002/$65,001/$100,000 |
#2Josh Gottheimer democrat · House · NJ-5 joint |
| $5,002/$40,001/$75,000 |
#3Jefferson Shreve republican · House · IN-6 self |
| $15,001/$32,501/$50,000 |
#4Ro Khanna democrat · House · CA-17 spouse |
| $2,001/$16,001/$30,000 |
#5Donald J Trump republican · Executive self |
| 3/26/49 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app